WHO-GMP Certified Commercial Pack · Product Code: AKP-105
Dapoxetine 30 mg & Tadalafil 20 mg Tablets
Formulation Overview: Long-duration dual-action formulation uniting tadalafil (20 mg) with rapid-onset dapoxetine 30 mg for sustained hemodynamic response and improved ejaculatory control. Formulated with Dapoxetine 30 mg + Tadalafil 20 mg (30 mg + 20 mg) in Film-Coated Tablets dosage form under Sexual Wellness Medication, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu / Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-105 |
|---|---|
| Catalog Reference | AKP-105 · SN 105 |
| Therapeutic Sector | Sexual Wellness Medication |
| Dosage Form | Film-Coated Tablets |
| Active Ingredient | Dapoxetine 30 mg + Tadalafil 20 mg |
| Strength / Purity | 30 mg + 20 mg |
| Clinical Indication | Co-existing erectile dysfunction and premature ejaculation requiring extended 36-hour therapeutic window |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu / Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C in a dry place, protect from light and moisture |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |